CardioGenics Holdings (CardioGenics Holdings) Net Change in Cash : $0.01 Mil (TTM As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

CardioGenics Holdings's Net Change in Cash for the three months ended in Jan. 2016 was $0.05 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2016 was $0.01 Mil.

CardioGenics Holdings Net Change in Cash Historical Data

The historical data trend for CardioGenics Holdings's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Net Change in Cash Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Net Change in Cash

Get a 7-Day Free Trial

-1.18

-0.64

0.24

-0.19

-0.02

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Net Change in Cash	Get a 7-Day Free Trial															0.01	-0.05	0.01	-	0.05

CardioGenics Holdings Net Change in Cash Calculation

CardioGenics Holdings's Net Change in Cash for the fiscal year that ended in Oct. 2015 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-0.607	+	-0.002	+	0.365	+	0.223
	=	-0.02

CardioGenics Holdings's Net Change in Cash for the quarter that ended in Jan. 2016

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0.03 + -0.283 + 0.414 + -0.114

= 0.05

Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CardioGenics Holdings Net Change in Cash Related Terms
Thank you for viewing the detailed overview of CardioGenics Holdings's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Net Change in Cash

Comparable Companies

TEAR NGM:LIFE B TSXV:AVCR BOM:541299 TSXV:TELO BOM:526546 OPGN XCNQ:LNB TSXV:IDL ASX:CTE TSXV:MBI.H BOM:538019 BOM:526504 BOM:526301 DCTH ABMC XSAT:ALPH WAR:NST XLRM ASX:LSH

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines